In today's stable society, health is the most important thing in people's hearts, and health is closely related to medicine. Accurate and efficient data can help researchers or doctors quickly screen for suitable anti-tumor compounds. It integrates data from medicinal chemistry, pharmacology and pharmacogenomics, and records the chemical structure, targets, and mechanism of action of anti-tumor drugs in detail. The establishment of the database of anti-tumor protein drugs can effectively promote the process development process of innovative drugs and generic drugs. To provide a sharing platform for researchers and clinicians to exchange and share research results and clinical experience of anti-tumor drugs, and to promote academic exchanges and cooperation in the field. It can help doctors quickly obtain the indications and contraindications of drugs, and formulate accurate treatment plans for patients based on their conditions and genetic characteristics. To a certain extent, the database can promote the innovation and development of new drugs, help improve R&D efficiency, reduce procurement and trial costs, and achieve sustainable research.